Alx Oncology Holdings (ALXO) Total Liabilities (2019 - 2026)

Alx Oncology Holdings has reported Total Liabilities for 8 years, with the latest figure at $27.0 million in Q1 2026.

• Quarterly Total Liabilities fell 17.25% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.0 million (down 17.25% YoY) and the FY2025 annual result came in at $33.1 million, down 3.2% from the prior year.
• Total Liabilities declined to $27.0 million in Q1 2026 per ALXO's latest filing, from $33.1 million in the prior quarter.
• Over five years, Total Liabilities peaked at $55.3 million in Q2 2024 and troughed at $20.1 million in Q1 2022.
• A 5-year average of $38.1 million and a median of $34.2 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities jumped 151.11% in 2022, then plunged 44.11% in 2025.
• Over 5 years, Total Liabilities stood at $43.0 million in 2022, then increased by 22.81% to $52.8 million in 2023, then sank by 35.36% to $34.2 million in 2024, then fell by 3.2% to $33.1 million in 2025, then dropped by 18.4% to $27.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $27.0 million, $33.1 million, and $37.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.